Robinhood Markets (NASDAQ: HOOD) ended 2025 on a high note. But its leadership is tempering expectations for the year ahead, thanks to market uncertainties. In an interview with CNBC, Robinhood chief investment officer Stephanie Guild said the company expects growth to continue in 2026, but at a slower pace. Related: Robinhood acquires crypto exchange Bitstamp despite SEC lawsuit threat Robinhood’s strong 2025 performance Founded in 2013, Robinhood became a publicly traded company in 2021 and joined th ...

Meta closing out 2025 with an 11th hour acquisition. Got a few of those in the tech space this week. The company announcing it is buying Manis, a startup founded in China that builds AI agents.Mackenzie Sagalas has more in today's tech check segment. Mac, and it's interesting to see Meta outperforming, too. >> Yeah, it is.Investors are bullish on this and part of that is the fact that it's a deal that speaks directly to the pressure pressure Meta CEO Mark Zuckerberg is facing to show returns on the company' ...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Templeton Emerging Markets Fund [NYSE: EMF]: Notification of Sources of Distributions Pursuant to Section 19(a) of the Investment Company Act of 1940 Â The Fund's estimated sources of the distribution to be paid on December 31, 2025, and for the fiscal year 2026 year-to-date are as follows: Estimated Allocations for December Quarterly Distribution: Distribution Per Share Net Investment Income Net Realized Short-Term Capital Gains Net Realized Long-Term Ca. ...

PayPal Holdings, Inc. (NASDAQ:PYPL) is among the ridiculously cheap stocks to buy now. As of December 26, PayPal Holdings, Inc. (NASDAQ:PYPL) has mixed analyst ratings, with 37% recommending buying the stock, 52% keeping a neutral stance, and the remaining 11% bearish on the stock. While the median price target of $75 reflects an upside potential of 25.06%, the highest and lowest price targets translate to an upside potential of 75.09% and a downside potential of 14.96%. On December 22, Mizuho trimmed th ...

Key Takeaways OMC has gained 11.7% over the past month, outperforming its industry's 7.4% rally.Omnicom has seen upward estimate revisions for 2025 and beat earnings in the last four quartersOMC's 2025 outlook calls for revenue and EPS growth, aided by Omni and the Interpublic acquisition.Omnicom Group (OMC) , one of the largest advertising, marketing and corporate communications companies, has delivered strong performance over the past month and shows potential to sustain the momentum in the near term. Con ...

Key Takeaways Coty posted mid-single-digit e-commerce sell-out growth in fiscal Q1 across Prestige and Consumer Beauty.COTY increased e-commerce penetration to about 20% of total sales during the quarter.Coty embedded digital teams locally and expanded AI use to improve execution and the shopping experience.Coty Inc.’s ((COTY) first-quarter fiscal 2026 performance highlights the growing strategic relevance of e-commerce, even as it navigates broader top-line pressure from trade destocking. In the fiscal fir ...

As most investors have noticed recently, precious metals like gold, silver, and platinum have been surging. I have been bullish on precious metals for a while. In March 2025, I suggested "backing up the truck" on gold mining stocks inLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: @ ...

Personalis, Inc. (NASDAQ:PSNL) is among the 12 Best Genomics Stocks to Invest In. Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL) The Fly reported on December 2, 2025, that Morgan Stanley analyst Kallum Titchmarsh took over coverage of Personalis, Inc. (NASDAQ:PSNL) with an Equal Weight rating and a price objective of $11, up from $9. The firm identified several upcoming catalysts within its coverage universe starting in 2026 and outlined growing bright spots across life s ...

Absci Corporation (NASDAQ:ABSI) is among the 12 Best Genomics Stocks to Invest In. Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that the first healthy volunteers had been dosed in the Phase 1/2a HEADLINE clinical trial investigating ABS-201, an experimental anti-prolactin receptor antibody built on its generative AI system. The Phase 1/2a trial is intended to evaluate effectiveness, pharmacokinetics ...

Joining us now is Cityroup's head of US equity strategy, Scott Croner. Scott, you you guys have a pretty rosy view of of the year ahead. Does this sort of final action tell you anything.>> Hey Sarah, happy new year. I guess we can say I'm not the mystery broker, otherwise I wouldn't be on here. So that's going to be very interesting to watch.But look at what what I would say our view is that you know this this boom versus bubble discussion keeps coming up and we're in the boom phase and in our view which we ...